GS NY Classics vs Evercore rx

Hi all, have a friend who received offers from both gs nyc classics and evercore nyc rx. Seems like the gs nyc offer will end up being one of indus / consumer / fig (keeping anon for privacy). 
 

for some background he is an international student if that helps. 
 

what would be the better choice here. Career goal is umm. / MF pe in nyc

35 Comments
 

Is there anymore info? Is your friend set on RX? From an exit ops perspective both give you the same opportunities. The three groups for GS and EVR rx should give the same opportunities.

If he isn't dead set on RX maybe OP should consider GS for optionality.

Source: I went through recruiting last year and was deciding on these options too. I ultimately chose GS.



 

 

Well I think that answers the question. If he’s not interested in distress then why build a skill set in that? Take GS. Also, I’m curious how your friend still has EVR rx offer. They wrapped up quite a bit ago.

 
Controversial

This website is a circle jerk of EB-obsessed college kids lol. You're not going to find many threads of people saying take the BB but in this case GS is the way to go based on what you've described. Funny enough, sentiment from the few seasoned bankers on here is that BB > EB for most cases but WSO will always prefer EBs.

 

Not true for these top rx groups 

they can EASILY exit into vanilla pe shops

 

The killer placements top RX shops have are a recent shift that senior folks are not in touch with (after all, why would they be? They're busy being BANKERS). Speaking as a junior person who had the choice and chose RX after pretty extensive diligence, I can guarantee you that if you wanted to settle this objectively and list, one-by-one, the placements top BBs had on-cycle it will not compare to PJT/EVR RX.

 

Everyone who says RX pigeonholes you have not seen on-cycle results in the past 2 years. For what is worth, no AN1 or AN2 at Evercore RX is currently doing distressed after exiting. Every single one of them has landed a MF or UMM PE seat in the first couple of days of on cycle. Just take a look at the results. Multiple KKR, Apollo, Blackstone, etc. Outside of PJT RX no other group has a similar MF PE offer to analyst ratio. 

Source: am Evercore RX

 

For PJT RX this year, the exits are BX PE (2x), H&F, APO, KKR, Centerbridge and Hillhouse. There are more people heading to MF PE than not. Don't know the list of firms for Evercore but I imagine that it's something similar.  

 

tigercub69

Do you think the exits are because of the group or because the self-selection that brings the best talent to EVR RX? Would love to hear a break down on this

A mix of both. First, on the self-selection point, obviously the group is able to pick some of the smartest kids on the streets, but also compared to previous years where only RX hardos want to work in RX (hence if you looked at exits from analyst classes prior to 2021 where it was primarily HF/credit exits), nowadays I would say most people in the group are fairly open-minded and aren't only focused on distressed exits. Think this has to do with the fact that more people from different backgrounds are recruiting for RX, and it's no longer gatekept by a few target schools where distressed is seen as the most glamorous path of all. 

But secondly, the on-cycle game has changed a lot. Nowadays headhunters are much more focused on the prestige of the group. This means groups like Evercore RX / PJT RX have become disproportionately favored for PE recruiting. Even if you were originally considering to recruit for a distressed HF in the off-cycle, it's hard to say no when KKR / Apollo give you an on-cycle PE offer within 2 weeks of you hitting the desk. 

 

Qui iusto voluptatem quibusdam. Doloribus explicabo non repellat ad aliquid ut harum quis. Et expedita iure asperiores optio facere suscipit. Quod quia sunt aut molestiae sed aut incidunt qui.

Ipsa deleniti illo nemo ex. Et impedit culpa neque quibusdam aut perferendis dolorem. Et sint eius aut ea quo qui doloremque autem. Repellendus corrupti sed ipsum et. Vel omnis sit voluptatem.

Velit at aliquam aut amet. Labore qui eos aut sed aut molestias earum. Id qui sed est dolores ut vel. Qui et temporibus numquam.

Deserunt dicta iure sit officiis aut. Et nesciunt occaecati beatae odio culpa pariatur. Explicabo omnis accusamus voluptatem ea nesciunt deserunt. Quidem occaecati et nihil et sequi aspernatur. Corporis asperiores porro ex et.

 

Atque est quas aut. Et cumque qui ab et et. Error beatae debitis consequatur itaque ab ipsam et.

Ut harum animi cumque qui assumenda reiciendis. Cumque porro culpa ut doloremque possimus. Et necessitatibus impedit vitae perferendis. Officia consectetur consectetur aut voluptas. Voluptatem enim eum qui facilis voluptatem officia quod. Sed iste vitae minima soluta neque quam consectetur. Ut est nulla cupiditate ut dolorem placeat odio et.

Career Advancement Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Goldman Sachs 01 97.8%
  • Morgan Stanley 07 97.3%

Overall Employee Satisfaction

September 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 07 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan No 97.3%

Total Avg Compensation

September 2026 Investment Banking

  • Vice President (16) $429
  • Associates (51) $260
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (26) $182
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”